ArrePath was founded upon the mission to discover new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel strategies.

We apply world-class science and innovation in imaging and AI / ML technologies to identify and develop novel drugs to address global health issues.

Our advanced machine learning (ML) and imaging-based drug discovery platform enables a rapid and efficient identification of new drug classes with desired activity profiles and clinical utility, coupled with a deep understanding of mechanism of action at the outset of the discovery process.

Biotechnology

ArrePath

Kurt Thorn

Fei Shen

Dylan Morris

The Science and Research Team at ArrePath is dedicated to discovering and developing novel anti-infective drugs to combat antimicrobial resistance (AMR). Utilizing advanced imaging and artificial intelligence/machine learning (AI/ML) technologies, the team rapidly identifies new drug classes, elucidates their mechanisms of action, and ensures clinical efficacy. The team is composed of experts in medicinal chemistry, data science, computer vision, and machine learning to drive innovative solutions in the drug discovery process.

Science and Research Team

About

Team members

Other teams at ArrePath

Board Members and Advisors

Leadership Team